Bioactive by-products
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-03375 | ||
RP-1551-4 is a compound in the class of azaphilone produced by Penicillium sp. SPC-21609. It inhibits the binding of PDGF AA to the extracellular domain of PDGF alpha-receptor. |
||
BBF-03376 | ||
RP-1551-5 is a compound in the class of azaphilone produced by Penicillium sp. SPC-21609. It inhibits the binding of PDGF AA to the extracellular domain of PDGF alpha-receptor. |
||
BBF-03377 | ||
RP-1551-6 is a compound in the class of azaphilone produced by Penicillium sp. SPC-21609. It inhibits the binding of PDGF AA to the extracellular domain of PDGF alpha-receptor. |
||
BBF-03378 | ||
RP-1551-7 is a compound in the class of azaphilone produced by Penicillium sp. SPC-21609. It inhibits the binding of PDGF AA to the extracellular domain of PDGF alpha-receptor. |
||
BBF-03379 | ||
RP-1551-8 is a compound in the class of azaphilone produced by Penicillium sp. SPC-21609. It inhibits the binding of PDGF AA to the extracellular domain of PDGF alpha-receptor. |
||
BBF-03380 | ||
RP-1551-9 is a compound in the class of azaphilone produced by Penicillium sp. SPC-21609. It inhibits the binding of PDGF AA to the extracellular domain of PDGF alpha-receptor. |
||
BBF-03381 | ||
RP-1776 is a cyclic peptide isolated from the culture broth of Streptomyces sp. KY11784. It selectively inhibits the binding of PDGF BB to the extracellular domain of the PDGF beta-receptor with an IC50 value of 11 ± 6 µmol/L. |
||
BBF-03382 | ||
RP-66453 is a secondary peptide metabolite produced by Streptomyces sp. A 9738. It can selectively bind to neurotensin receptor. |
||
BBF-03392 | ||
S14-95 is an inhibitor of the JAK/STAT pathway isolated from Penicillium sp. 14-95. It inhibits the IFN-gamma mediated expression of the reporter gene with IC50 values of 2.5 to approximately 5 mg/ml. It inhibits the expression of the proinflammatory enzymes COX-2 and NOS II at 5 microg/ml (10.8 mM) in LPS/IFN-gamma stimulated J774 mouse macrophages. |
||
BBF-03397 | ||
S-19159 is a modulator of neurite outgrowth produced by the ascomycete Preussia aemulans. |
||
BBF-03446 | ||
FA 5859 is an amino acid compound produced by the strain of Emericella quidrilineata (IFO 5859), Aspergillus sp. 3704. It has the activity of inhibiting fatty acid degradation. |
||
BBF-03525 | ||
Pironetin is a plant growth regulator produced by Streptomyces sp. NK10958. |
||
BBF-03535 | ||
RES-701-1 is an endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. It selectively inhibits the ET-1 binding to endothelin type B receptor. |
||
BBF-03555 | ||
FR225659 is originally isolated from Helicomyces sp. No. 19353. It can suppress the gluconeogenesis induced by Glucagon in Primary hepatocytes of rats. |
||
BBF-03567 | ||
FR 900525 is a metabolite produced by the strain of Streptomyces tsukubaensis No. 9993. It has antifungal activity. |
||
BBF-03740 |
Glucopiericidinol A1 (125535-05-9) Inquiry |
|
It is produced by the strain of Streptomyces sp. OM-5689. It has anti-Hela S3 activity (MIC is 0.39 μg/mL), similar to Glucopiericidin (MIC is 0.25 μg/mL). |
||
BBF-03741 |
Glucopiericidinol A2 (125591-38-0) Inquiry |
|
It is produced by the strain of Streptomyces sp. OM-5689. It has anti-Hela S3 activity (MIC is 0.10 μg/mL), similar to Glucopiericidin (MIC is 0.25 μg/mL). |
||
BBF-03922 |
Pyrrole-2-carboxylic acid (634-97-9) Inquiry |
|
Small amphoteric polar metabolite produced by many streptomyces species; An important dereplication standard in discovery, displaying a distinctive UV spectrum and a broad range of biological activities, albeit weak; Demonstrated antiparasitic activity against trypanosomes by selective proline racemase inhibition and has potent antifungal activity against phytophthora. |
||
BBF-03934 |
Ivermectin B1b (70209-81-3) Inquiry |
|
Ivermectin B1b is a minor component of Ivermectin, a semi-synthetic derivative of Abamectin. Ivermectin is a medication that is effective against many types of parasites. |
||
BBF-03990 |
Transplatin (14913-33-8) Inquiry |
|
The less-active isomer of the DNA damanging, platinum antitumor drug cisplatin. Transplatin is used in the treatment of a variety of solid tumors. Transplatin's anti-tumor activity can be activated by light. |